Divi’s Laboratories (DIVISLAB) Share Price Rises 2.14% Today
- September 7, 2026
- Posted by: Kunal Singla
- Category: News
Divi’s Laboratories Share Price is trading at Rs 9,409.8, up 2.14% today, with market capitalisation at Rs 2,46,737.12 crore. The move keeps Divi’s Laboratories Share Price in focus in the healthcare pack as investors track the price rise alongside valuation and sector context.That makes the stock relevant today because the share price gain is measurable, the market cap is substantial, and the valuation remains a key part of any Divi’s Laboratories Share Price discussion. In the first half of the session, the stock stayed above the previous close and moved near the day high, which gives a clear price action picture for Divi’s Laboratories Share Price today.
Divi’s Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 9,409.8 |
| Previous Close | Rs 9,212.85 |
| Today's Move | Rs 196.95 (+2.14%) |
| Open | Rs 9,212.85 |
| High | Rs 9,410.95 |
| Low | Rs 9,168.1 |
| Market Capitalisation | Rs 2,46,737.12 crore |
| Market Cap Category | Large Cap |
Divi's Laboratories Ltd. (DIVISLAB) rose to Rs 9,409.8 from the previous close of Rs 9,212.85, a move of Rs 196.95 or 2.14%. The stock opened at Rs 9,212.85, reached a high of Rs 9,410.95, recorded a low of Rs 9,168.1.
Divi’s Laboratories Share Price is up 2.14% today after moving from the previous close of Rs 9,212.85 to Rs 9,409.8. The stock opened at Rs 9,212.85, touched a high of Rs 9,410.95 and a low of Rs 9,168.1, showing a contained intraday range while staying well bid above the previous close. For Divi’s Laboratories Share Price, that places the move in the context of a steady share price rise rather than a sharp gap or reversal. The latest Univest figures also show a market capitalisation of Rs 2,46,737.12 crore, which keeps Divi’s Laboratories Share Price firmly visible among healthcare names trading today. The key takeaway is simple: the stock is rising today on a quantified price move, and the next step is to weigh that against fundamentals.
Why Divi’s Laboratories Ltd. (DIVISLAB) May Be Moving Today
Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,46,737.12 crore |
| P/E Ratio | 83.61x |
| P/B Ratio | 13.85x |
| ROE | 16.19% |
| ROCE | 21.51% |
| EPS | Rs 110.18 |
| Book Value Per Share | Rs 665.36 |
| Dividend Yield | 0.33% |
Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 83.61x, P/B 13.85x, ROE 16.19%, ROCE 21.51%. Taken on their own, these numbers offer context rather than a trading signal.
Divi’s Laboratories Ltd. has a market capitalisation of Rs 2,46,737.12 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 83.61x, P/B at 13.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.33%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.79x, median ROE of 11.73%, median ROCE of 13.63%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 83.61x |
| Benchmark Median P/E | 31.79x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.58x to 668.09x |
| Company P/B Ratio | 13.85x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 16.19% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 21.51% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 2,46,737.12 crore |
| Benchmark Median Market Cap | Rs 812.84 crore |
Divi's Laboratories Ltd. (DIVISLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 83.61x, which is above the benchmark median of 31.79x, a difference of +163.01%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.73%, a difference of +38.02%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.63%, a difference of +57.81%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,34,279.63 | 35.35 | 4.94 | 14.85 | 19.11 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,81,129.27 | 82.93 | 20.15 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,239.13 | 25.16 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,08,808.05 | 31.97 | 3.07 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,07,468.1 | 97.06 | 18.82 | 18.31 | 18.2 |
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 83.61x compared with the displayed peer median of 35.35x. The comparison is relative and should not be read as a recommendation. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,46,737.12 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching Divi’s Laboratories Share Price
- Divi’s Laboratories Share Price is trading higher today, and the move is clearly measurable against the previous close.
- Divi’s Laboratories Share Price is carrying a premium valuation, so P/E, P/B and return ratios remain central to analysis.
- Divi’s Laboratories Share Price is above the industry median for ROE and ROCE, which keeps fundamentals in focus.
- Divi’s Laboratories Share Price is also being watched for how it compares with healthcare peers on valuation and market cap.
- Divi’s Laboratories Share Price may stay active as investors assess the index-inclusion related market discussion alongside price action.
About Divi’s Laboratories
Divi’s Laboratories Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The business profile places Divi’s Laboratories Share Price in the context of a company known for pharmaceutical manufacturing rather than consumer-facing products. Divi’s Laboratories Share Price is therefore influenced by company financials, industry benchmarks and valuation discipline more than by a simple product-cycle narrative. The company sits among the better-known listed healthcare names in India, and its scale is visible through the market capitalisation and peer set used in this article. For readers following Divi’s Laboratories Share Price, the important context is that the company belongs to a sector where return ratios, earnings quality and book value often carry significant weight in stock analysis. Univest tracks that combination so readers can follow Divi’s Laboratories Share Price alongside sector and peer context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Divi's Laboratories Share Price rising today?
Ans. Divi's Laboratories Share Price is rising today by 2.14% to Rs 9,409.8.
What is Divi's Laboratories Share Price today?
Ans. Divi's Laboratories Share Price is Rs 9,409.8, compared with the previous close of Rs 9,212.85. The move leaves the stock higher by Rs 196.95 in the current session.
What is Divi's Laboratories market cap right now?
Ans. Divi's Laboratories has a market capitalisation of Rs 2,46,737.12 crore. That scale places Divi's Laboratories Share Price well above the industry median and average market cap in the same industry benchmark.
How does Divi's Laboratories Share Price compare with peers on valuation?
Ans. Divi's Laboratories Share Price has a P/E of 83.61 and a P/B of 13.85. Both are above several peers such as Sun Pharma, Cipla, Zydus Lifesciences and Dr. Reddy's Laboratories.
Is Divi's Laboratories Share Price expensive compared with the industry?
Ans. Divi's Laboratories Share Price trades at a premium to the industry median P/E of 31.79 and P/B of 2.9. The return ratios are also above the industry median, which adds context to that valuation.
What do ROE and ROCE show for Divi's Laboratories?
Ans. Divi's Laboratories reports ROE of 16.19% and ROCE of 21.51%. For Divi's Laboratories Share Price, these figures indicate stronger return generation than the industry median and average in the same benchmark set.
What do EPS and book value mean for Divi's Laboratories Share Price?
Ans. EPS is 110.18 and book value is Rs 665.36. For Divi's Laboratories Share Price, EPS reflects earnings per share, while book value shows the accounting net worth behind each share.
Should investors track Divi's Laboratories Share Price on Univest?
Ans. Yes, Divi's Laboratories Share Price can be tracked on Univest for live price, valuation ratios, market capitalisation and 52-week levels. It helps place the day’s price rise alongside company financials and sector context.
Track Divi’s Laboratories Share Price on Univest
Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Divi’s Laboratories Share Price on Univest for live updates on the stock price, market capitalisation, valuation ratios, 52-week levels and broader market insights. Divi’s Laboratories Share Price today is best read with fundamentals, sector context and peer comparison together, and Univest presents those checks in a single view. If Divi’s Laboratories Share Price moves again, the same framework helps place the move against price action, company financials and industry benchmarking without over-reading one trading phase.
